ישראל - עברית - Ministry of Health

teva israel ltd - metformin hydrochloride; vildagliptin - טבליות מצופות פילם - metformin hydrochloride 1000 mg; vildagliptin 50 mg - metformin

ישראל - עברית - Ministry of Health

teva israel ltd - metformin hydrochloride; vildagliptin - טבליות מצופות פילם - metformin hydrochloride 850 mg; vildagliptin 50 mg - metformin

ישראל - עברית - Ministry of Health

teva medical ltd - dextrose monohydrate; potassium chloride; sodium chloride - תמיסה להזרקה - sodium chloride 330 mg / 100 ml; potassium chloride 150 mg / 100 ml; dextrose monohydrate 5 g / 100 ml - potassium chloride - electrolyte solutions - indicated for replenishing water, certain electrolytes and calories required by the clinical condition of the patient.

ישראל - עברית - Ministry of Health

teva medical marketing ltd. - glucose as monohydrate - תמיסה להזרקה - glucose as monohydrate 10 % - glucose - glucose - as intravenous injection: dextrose 10 % injection is indicated as a source of water and calories. as parenteral nutrient: dextrose 10 % injection is indicated as a caloric component in parenteral nutrition regimen. it is used with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: 1) the alimentary tract cannot should not be used. 2) gastrointestinal absorption of protein is impaired, or 3) metabolic requirements for protein are substantially increased, as extensive burns.

ישראל - עברית - Ministry of Health

teva medical ltd - calcium chloride dihydrate; dextrose monohydrate; magnesium chloride hexahydrate; sodium chloride; sodium lactate - תמיסה לדיאליזה פריטוניאלית - dextrose monohydrate 2.5 g / 100 ml; sodium chloride 538 mg / 100 ml; sodium lactate 448 mg / 100 ml; calcium chloride dihydrate 25.7 mg / 100 ml; magnesium chloride hexahydrate 5.08 mg / 100 ml - isotonic solutions - indicated for use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis

ישראל - עברית - Ministry of Health

novartis israel ltd - crizanlizumab - תרכיז להכנת תמיסה לאינפוזיה - crizanlizumab 10 mg/ml - crizanlizumab

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - atorvastatin as calcium - טבליה - atorvastatin as calcium 10 mg - atorvastatin - atorvastatin - atorvastatin teva is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. atorvastatin teva is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - atorvastatin as calcium - טבליה - atorvastatin as calcium 10 mg - atorvastatin - atorvastatin - atorvastatin teva is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. atorvastatin teva is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl

ישראל - עברית - Ministry of Health

abic marketing ltd, israel - olanzapine - טבליות מצופות פילם - olanzapine 10 mg - olanzapine - olanzapine - acute and maintenance treatment of schizophrenia. olanzapine teva is indicated for the management of the manifestations of psychotic disorders. olanzapine teva is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. prevention of recurrence in bipolar disorder : in patients whose manic episode has responded to olanzapine treatment olanzapine teva is indicated for the prevention of recurrence in patients with bipolar disorder. combination therapy in bipolar i disorder: the combination of olanzapine teva with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.

ישראל - עברית - Ministry of Health

eldan electronic instruments co ltd, israel - dextrose anhydrous - תמיסה לאינפוזיה - dextrose anhydrous 5 %